HeadWise Podcast on migraine and headache news

News Edition April 2023

April 2023, Episode 153: In this Headwise News Episode, Lindsay Weitzel, Ph.D., talks to headache specialist and clinical trial expert Tim Smith, MD, about three new medication announcements plus an exciting new study linking genetic, hormone, and circadian data to…

Read More

News Edition February 2023

March 2023, Episode 149: Is it safe to take ubrogepant and atogepant together? What is Pulmatrix? What’s new in cluster headache? What are the latest MRI findings in migraine? Are migraine triggers as numerous and as important as we think?…

Read More

Migraine Medical Update – Nocira Gets Breakthrough Device Status

June 2022, Episode 124: Nocira Device for Migraine Very exciting news for the migraine community! In this week’s episode of Heads UP, Dr. Lindsay Weitzel and Dr. Timothy Smith discuss an up-and-coming migraine device being developed by a company called…

Read More

The Role of Genetics in Migraine

March 2022, Episode 115: How many of your relatives are affected by migraine? A recently published study found 123 genetic loci associated with migraine. This is nearly 40 more than were previously recognized. In this episode of Heads UP, Lindsay…

Read More

DATA Alert on Intranasal Zavegepant

January 2022, Episode 109: New Data Alert on the Up-and-Coming Migraine Medication: Intranasal Zavegepant. While not yet approved for release, intranasal zavegepant has shown promise in some interesting and unique data points in the relief of acute migraine. What is…

Read More

Atogepant and Migraine

October 2021, Episode 103: Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard…

Read More

Impel Neuropharma Graphic

Trudhesa Nasal Spray for the Acute Treatment of Migraine

September 2021, Episode 101: Dr. Lindsay Weitzel talks to Dr. Tim Smith about the specifics of Trudhesa, the first DHE nasal spray to utilize Precision Olfactory Delivery (POD) technology. Trudhesa was just approved by the FDA. When will it be…

Read More

100 Heads Up Weekly Podcast Logo

NHF ‘Heads UP’ Podcast Reaches Centennial Episode Milestone

Podcast viewers who want to learn more about migraine and headache disorders look forward to the weekly “Heads UP” podcast hosted by Lindsay Weitzel, and on September 8th her 100th episode will air for the National Headache Foundation (NHF). The…

Read More

helmet-football photo

Q-Collar and the Prevention of TBI

April 2021, Episode 93: Have you ever noticed how woodpeckers can peck away at hard surfaces all day and never get a concussion? This is the inspiration behind a device newly approved by the FDA for the prevention of mild…

Read More

Heads UP - Episode 92: Cannabis, Migraine and Rebound Headache

Cannabis, Migraine and Rebound Headache

April 2021, Episode 92: Cannabis is used by many people with migraine and other headache disorders to help control their symptoms. In the last few years, some studies have shown it to be effective for some people. Recent data has…

Read More

Heads UP - Episode 88: Intracranial Hypertension and Aimovig (Erenumab)

Intracranial Hypertension and Aimovig (Erenumab)

March 2021, Episode 88: New data has shown that Aimovig (erenumab) is effective in treating intracranial hypertension, also known as high-pressure headache or pseudotumor cerebri. Dr. Lindsay Burgarello Weitzel and Dr. Timothy Smith discuss this exciting news for people living…

Read More

woman in the couch

Nerivio for Adolescents

February 2021, Episode 85: Dr. Lindsay Weitzel and Dr. Timothy Smith discuss the FDA’s recent approval of Nerivio for use in children older than 12 years of age. Nerivio is a smartphone-controlled wearable device used for the acute treatment of…

Read More